Bond Screener
BioMarin Pharmaceutical
LEI NSLL8ITTRR0J5HEMR848
Organization name
BioMarin Pharmaceutical Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
1,450 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
|
General information
-
Organization nameBioMarin Pharmaceutical Inc.
-
Organization statusOperating organization
-
Address105 Digital Drive Novato, USA, 94949
-
Site
News
-
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) Gains Momentum with Analyst Upgrade and Strategic Moves01/09/2026
-
BioMarin Pharmaceutical: Of The Original Report To Provide The Financial Statements And Pro Forma Financial Information Required By Items 9.01(a) And (b) Of Form 8k. Such Financial Information Was Excluded From The Original Report In Reliance On The Instructions To Such Items27/04/2026
-
BioMarin Pharmaceutical: Entry Into A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Creation Of A Direct Financial Obligation Or An Obligation Under An, Regulation Fd Disclosure, Financial Statements And Exhibits27/04/2026
-
BioMarin Pharmaceutical: Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An, Regulation Fd Disclosure, Financial Statements And Exhibits12/02/2026
-
New issue: BioMarin Pharmaceutical issued international bonds (USU09036AA91) with the coupon rate of 5.5% in the amount of USD 850 mln maturing in 203403/02/2026
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show more
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameBioMarin Pharmaceutical Inc.
-
Organization statusOperating organization
-
Address105 Digital Drive Novato, USA, 94949
-
Site
Codes
-
LEINSLL8ITTRR0J5HEMR848
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
NACE*** ***
-
NAICS*** ***
-
CIK0001048477
-
EIN68-0397820
